Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Qualcomm, Novartis To Invest In Mobile Health, Aggregate Trial Data

This article was originally published in The Gray Sheet

Executive Summary

The companies say they are partnering to invest in start-ups that have potential to change healthcare delivery and are using Qualcomm’s 2net Platform in a clinical trial to aggregate patient data and personalize treatments.

Advertisement

Related Content

Big Tech Firms Target Health Care Space With Cheap Sensors In Smartphones
Digital Health Briefs: Post-Surgery Remote Monitoring; NHS England Technology Funding; Qualcomm Product

Topics

Related Companies

Advertisement
UsernamePublicRestriction

Register

MT034071

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel